Ionizing Radiation

RADIATION2 trials

Sponsors

Angimmune LLC

Conditions

MelanomaStage IV Melanoma

Phase 1

A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma

TerminatedNCT01888081

Angimmune LLCMelanoma

Start: 2014-02-28Updated: 2016-11-23

A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma

Angimmune LLCStage IV Melanoma

Start: 2017-01-31End: 2018-06-30Target: 63Updated: 2016-12-13